References
- Abbott RD, Wilson PW, Kannel WB, Castelli WP. 1988. High density lipoprotein cholesterol, total cholesterol screening, and myocardial infarction. The Framingham Study. Arteriosclerosis. 8:207–211.
- Adiels M, Olofsson SO, Taskinen MR, Borén J. 2006. Diabetic dyslipidaemia. Curr Opin Lipidol. 17:238–246.
- Aeschbach R, Loliger J, Scott BC, Murcia A, Butler J, Halliwell B, Aruoma OI. 1994. Antioxidant actions of thymol, carvacrol, 6-gingerol, zingerone and hydroxytyrosol. Food Chem Toxicol. 32:31–36.
- Al-Shamaony L, Al-Khazraji SM, Twaij HA. 1994. Hypoglycaemic effect of Artemisia herba alba. II. Effect of a valuable extract on some blood parameters in diabetic animals. J Ethnopharmacol. 43:167–171.
- Babu LH, Perumal S, Balasubramanian MP. 2012. Myrtenal, a natural monoterpene, down-regulates TNF-α expression and suppresses carcinogen-induced hepatocellular carcinoma in rats. Mol Cell Biochem. 369:183–193.
- Bastos JF, Moreira IJ, Ribeiro TP, Medeiros IA, Antoniolli AR, De Sousa DP, Santos MR. 2010. Hypotensive and vasorelaxant effects of citronellol, a monoterpene alcohol in rats. Basic Clin Pharmacol Toxicol. 106:331–337.
- Borggreve SE, DeVries R, Dullaart RPF. 2003. Alterations in high-density lipoprotein metabolism and reverse cholesterol transport in insulin resistance and type 2 diabetes mellitus: role of lipolytic enzymes, lecithin: cholesterol acyltransferase and lipid transfer proteins. Eur J Clin Invest. 33:1051–1069.
- Celio L, Meloa D, Maria R, Queiroza G, Said Fonsecaa GC, Ayla Bizerrab MC, Telma Lemosb LG, Tiago Meloc S, Flavia Santosc A, Vietla Rao S. 2010. Oleanolic acid, a natural triterpenoid improves blood glucose tolerance in normal mice and ameliorates visceral obesity in mice fed a high-fat diet. Chem Biol Interact. 185:18559–18565.
- Cohn RM, Roth KS. 1996. Lipid and lipoprotein metabolism. Biochemistry and disease. Baltimore: Williams and Wilkins Publishers.
- Deepa B, Anuradha CV. 2011. Linalool, a plant derived monoterpene alcohol, rescues kidney from diabetes induced nephropathic changes via blood glucose reduction. Diabetol Croat. 40–44.
- Duvillard L, Pont F, Florentin E, Galland-Jos C, Gambert P, Vergès B. 2000. Metabolic abnormalities of apolipoprotein B-containing lipoproteins in noninsulin-dependent diabetes: a stable isotope kinetic study. Eur J Clin Invest. 30:685–694.
- Ezhumalai M, Radhiga T, Pugalendi KV. 2014. Antihyperglycemic effect of carvacrol in combination with rosiglitazone in high-fat diet-induced type 2 diabetic C57BL/6J mice. Mol Cell Biochem. 385:23–31.
- Falholt K, Falholt W, Lund B. 1973. An easy colorimetric micro method for routine determination of free fatty acids in plasma. Clin Chim Acta. 46:105–111.
- Folch J, Lees M, Solane SGH. 1957. A simple method for isolation and purification of total lipids from animal tissues. J Biol Chem. 26:497–509.
- Fossati P, Lorenzo P. 1982. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem. 28:2077–2080.
- Frayn KN. 1993. Insulin resistance and lipid metabolism. Curr Opin Lipidol. 4:197–204.
- Friedwald WT, Levy RI, Fredrickson DS. 1972. Estimation of the concentration of LDL-C in plasma without use of the preparative ultracentrifuge. Clin Chem. 18:449–502.
- Garvey WT, Kwon S, Zheng D, Shaughnessy S, Wallace P, Hutto A, Pugh K, Jenkins AJ, Klein RL, Liao Y. 2003. Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance. Diabetes. 52:453–462.
- Golay A, Chen YD, Reaven GM. 1986. Effect of differences in glucose tolerance on insulin stability regulate carbohydrate and free fatty acid metabolism in obese individuals. J Clin Endocrinol Metabol. 86:1081–1088.
- Hitz J, Steinmetz J, Siest G. 1983. Plasma lecithin: cholesterol acyltransferase-reference values and effects of xenobiotics. Clin Chim Acta. 133:85–96.
- Kim H, Jeong D, Jung H, Jung YJ, Yokozawa T, Choi JS. 2008. Hypolipidemic effects of sophora flavescens and its constituents in poloxamer407-induced hyperlipidemic and cholesterol-fed rats. Biol Pharm Bull. 31:73–78.
- Korn ED. 1955. Clearing factor, a heparin-activated lipoprotein lipase. I. Isolation and characterization of the enzyme from normal rat heart. J Biol Chem. 215:1–26.
- Kripa K, Vijayalakshmi NR, Helen A. 2011. Methanolic extract of costusigneus (N.E.Br.) alleviates dyslipidemia in diabetic rats. Asian J Pharm Clin Res. 4:154–157.
- Kudchodkar BJ, Lee JC, Lee SM, DiMarco NM, Lacko AG. 1988. Effect of dietary protein on cholesterol homeostasis in diabetic rats. J Lipid Res. 29:1272–1287.
- Kulkarni CR, Joglekar MM, Patil SB, Arvindekar AU. 2012. Antihyperglycemic and antihyperlipidemic effect of Santalumalbum in streptozotocin induced diabetic rats. Pharm Biol. 50:360–365.
- Lee S, Tsao R, Peterson C, Coats JR. 1997. Insecticidal activity of monoterpenoids to western corn rootworm (Coleoptera: Chrysomelidae) two-spotted spider mite (Acari: Tetranychidae), and house fly (Diptera: Muscidae). J Econ Entomol. 90:883–892.
- Manou L, Bouillard L, Devleeschouwer MJ, Barel AO. 1998. Evaluation of the preservative properties of Thymus vulgaris essential oil in topically applied formulations under a challenge test. J Appl Microbiol. 84:368–376.
- Marcio RVS, Flávia VM, Byanka PF, Damiao PDS, Leonardo RB, Lucindo JQJ. 2011. Cardiovascular effects of monoterpenes: a review. Rev Bras Farmacogn Braz J Pharmacogn. 21:764–771.
- Lindmark-Henriksson M, Isaksson D, Vanek T, Valterová I, Högberg HE, Sjödin K. 2004. Transformation of terpenes using a Picea abies suspension culture. J Biotechnol. 107:173–184.
- Moler DE. 2001. New drug targets for type 2 diabetes and metabolic syndrome. Nature. 414:821–827.
- Mooradian AD. 2009. Dyslipidemia in type 2 diabetes mellitus. Nat Clin Pract Endocrinol Metab. 5:150–159.
- Murali R, Saravanan R. 2012. Antidiabetic effect of d-limonene, a monoterpene in streptozotocin-induced diabetic rats. Biomed Prev Nutr. 2:269–275.
- Nielsen LB, Bartels ED, Bollana E. 2002. Over expression of apolipoprotein B in the heart impedes cardiac triglyceride accumulation and development of cardiac dysfunction in diabetic mice. J Biol Chem. 277:14–20.
- Okutan H, Ozcelik N, Yilmaz HR, Uz E. 2005. Effects of caffeic acid phenethyl ester on lipid peroxidation and antioxidant enzymes in diabetic rat heart. Clin Biochem. 38:191–196.
- Peixoto-Neves D, Silva-Alves KS, Gomes MD, Lima FC, Lahlou S, Magalhães PJ, Ceccatto VM, Coelho-de-Souza AN, Leal-Cardoso JH. 2010. Vasorelaxant effects of the monoterpenic phenol isomers, carvacrol and thymol, on rat isolated aorta. Fundam Clin Pharmacol. 24:341–350.
- Philipp B, Shapiro DJ. 1970. Improved methods for the assay and activation of 3-hydroxy-3-methylglutaryl coenzyme A reductase. J Lipid Res. 20:588–593.
- Punithavathi VR, Prince PS, Kumar R, Selvakumari J. 2011. Antihyperglycaemic, antilipid peroxidative and antioxidant effects of gallic acid on streptozotocin induced diabetic Wistar rats. Eur J Pharmacol. 650:465–471.
- Ramachandran V, Saravanan R. 2013. Efficacy of asiatic acid, a pentacyclic triterpene on attenuating the key enzymes activities of carbohydrate metabolism in streptozotocin-induced diabetic rats. Phytomedicine. 20:230–236.
- Rathinam A, Pari L, Chandramohan R, Sheikh BA. 2014. Histopathological findings of the pancreas, liver, and carbohydrate metabolizing enzymes in STZ-induced diabetic rats improved by administration of myrtenal. J Physiol Biochem. 70:935–946.
- Shepherd J. 2005. Does statin monotherapy address the multiple lipid abnormalities in type 2 diabetes? Atheroscler Suppl. 6:15–19.
- Singh IM, Shishehbor MH, Ansell BJ. 2007. High-density lipoprotein as a therapeutic target: a systematic review. J Am Med Assoc. 298:786–798.
- Tan BK, Tan CH, Pushparaj PN. 2005. Anti-diabetic activity of the semi-purified fractions of Averrhoa bilimbi in high fat diet fed-streptozotocin-induced diabetic rats. Life Sci. 76:2827–2839.
- Taskinen MR. 1987. Lipoprotein lipase in diabetes. Diabetes Metab Rev. 3:551–570.
- Vance JE, Vance DE. 2005. Metabolic insights into phospholipid function using gene targeted mice. J Biol Chem. 280:10877–10880.
- Verges B. 2009. Lipid modification in type 2 diabetes: the role of LDL and HDL. Fundam Clin Pharmacol. 23:681–685.
- Vibha JB, Choudhary K, Mangal S, Rathore MS, Shekhawat NS. 2009. A study on pharmacokinetics and therapeutic efficacy of Glycyrrhiza glabra. A miracle medicinal herb. Bot Res Int. 2:157–163.
- Zilversmit BB, Davis AK. 1950. Microdetermination of plasma phospholipids by trichloroacetic acid precipitation. J Lab Clin Med. 35:155–160.
- Zlatkis A, Zak B, Boyle GJ. 1953. A simple method for determination of serum cholesterol. J Clin Med Res. 41:486–492.